C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
11/2001
11/13/2001	US6316389 Dihydrobenzene pesticides
11/13/2001	US6316180 Monitoring sample for preferential particles; expose sample to label, incubate and detect luminescent signal from sample
11/13/2001	US6315384 Thermal inkjet printhead and high-efficiency polycrystalline silicon resistor system for use therein
11/08/2001	WO2001083491A1 Cephalosporin intermediates
11/08/2001	WO2001083473A1 Process for producing optically active sulfoxide derivative
11/08/2001	WO2001083465A2 Alkynyl phenyl heteroaromatic glucokinase activators
11/08/2001	WO2001083461A1 Thiazole and oxazole derivatives
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001056567A8 2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
11/08/2001	WO2001038317A3 Fungicidal melithiazole derivatives
11/08/2001	US20010039353 Water soluble prodrugs of azole compounds
11/08/2001	US20010039351 Reacting 7-(2-aminoethyl)-4-hydroxy-1,3-benzothiazole-2-one or its salt with 2-(3-etheneylsulfonylpropoxy)ethyl benzene in presence of solvent and tertiary amine base
11/08/2001	US20010039344 Antidiabetic agents
11/08/2001	US20010039278 Anorectic and antidiabetic agents
11/08/2001	US20010039275 Use of 2,4-diaminothiazole derivatives
11/08/2001	DE10019755A1 New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407189A1 New gamma selective retinoids
11/08/2001	CA2405832A1 P-(sulfonyl)aryl and heteroaryls
11/07/2001	EP1151998A1 Estrogen agonists/antagonists
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP1150565A1 Thiazole derivatives and combinatorial libraries thereof
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1321153A Telomerase inhibitors and method of their use
11/07/2001	CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1320599A Limited 9-cis-isotretinoins
11/07/2001	CN1320375A Herbicidal synergic composition and method for controlling weed
11/07/2001	CN1320374A Herbicidal synergic composition and method for controlling weed
11/07/2001	CN1320373A Herbicidal synergic composition and method for controlling weed
11/06/2001	USRE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
11/06/2001	US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides
11/06/2001	US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
11/06/2001	US6313306 N-(2-Mercaptoethyl)-1,3-thiazolidines and their use as odorants and flavorings
11/06/2001	US6313305 Cephalosporins
11/06/2001	US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313113 Azolidinedione derivatives, analogues, tautomeric forms, stereoisomers, polymorphs, salts and solvates; treating non-insulin-dependent diabetes mellitus
11/06/2001	CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes
11/01/2001	WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	US20010036924 Dietetics, immunomodulator, antiinflammatory agents
11/01/2001	CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	CA2402123A1 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
11/01/2001	CA2365320A1 Novel heterocyclic compounds
10/2001
10/31/2001	EP1149833A1 Sulfidoamidocarboxylic acids used as corrosion inhibitors
10/31/2001	EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
10/31/2001	EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001	EP0758326B1 Alkyl sulphinyl and alkyl sulphonyl-1,2,4-thiadiazolyloxy acetamides and their use as herbicides
10/31/2001	EP0719258B1 Cyclic amide derivatives for protecting against ultraviolet rays
10/31/2001	DE10008089A1 Production of tubulysin compounds comprises multi-stage process including condensation of N-methylpipecolinoyl-isoleucine with substituted thiazole-4-carboxylic acid derivative
10/31/2001	CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/31/2001	CN1320120A Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments
10/31/2001	CN1319587A Heterocyclonitrogen heteroethane derivant with antiviral activity
10/30/2001	US6310262 Process for preparing retiferol derivatives
10/30/2001	US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/30/2001	US6310096 Cyclohexadiene-derivatives as pesticides
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001	US6310069 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
10/30/2001	US6310052 Nitrate esters and their use for neurological conditions
10/30/2001	US6310050 Therapeutic use of compounds with β3-agonist activity
10/30/2001	US6309881 Aldehyde and ketone reactants are contacted with antibody molecules or molecules containing antibody combining site portions that catalyze an aldol addition reaction
10/25/2001	WO2001079478A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors
10/25/2001	WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001	WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	WO2001019798A3 Inhibitors of factor xa
10/25/2001	WO2000061541A8 Pharmaceutical compounds
10/25/2001	WO2000056724A9 Oxazole and thiazole combinatorial libraries
10/25/2001	US20010034452 Epothilons C and D, preparation and compositions
10/25/2001	US20010034342 Brain disorders, antiischeic agents
10/25/2001	US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/24/2001	EP1148054A1 Thyroid receptor ligands
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1146875A1 Myt1 kinase inhibitors
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	EP0856002B1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
10/24/2001	EP0854862B1 Process for the preparation of an activated amino acid
10/24/2001	EP0648212B1 Benzoxazole and benzothiazole derivatives as pharmaceutical
10/24/2001	CN1319088A Arylsulfonanilide ureas

1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 337